On November 10, 2011 Exco InTouch sponsored a Complimentary Web Seminar entitled:

Take Control of Patient Communication, Reduce Missing Data, and Maximize Compliance and Retention

The Challenge - Both FDA and the EMEA have put greater emphasis on the collection of full data sets for trial participants, with a particular focus being on the collection of data for critical endpoints at specified time points, as well as reason for withdrawal from study medication data. Statistically, over 85% of clinical trials in the US fail to recruit or retain enough patients, with the average patient drop-out rate across all clinical trials surveyed at 30%. High non-completion rates such as these can result in decreased quality of data, ineffective use of time and reduced statistical power in a study.

Exco InTouch today announced another success in the prestigious European Outsourcing Awards, held in Frankfurt on 26 October 2011. In the second year running that the company has received the EOA award, Exco InTouch has been honoured with the accolade of ‘Best eBusiness/IT strategy’, which recognizes Exco InTouch’s collaboration with Pfizer. The study, which focused on new Research on Electronic Monitoring of OAB Treatment Experience (REMOTE), is the first Participatory Patient-Centred (PPC) clinical trial to be conducted. The Phase 4 trial was facilitated with the use of proven mobile eDiary technology from Exco InTouch, enabling patients to participate regardless of location, age or proximity to site.

Exco InTouch, the leading provider of patient communication solutions for the pharmaceutical and healthcare sectors, today announced that it is a winner of the 2011 Deloitte Technology Fast 50. The awards, now in their 14th year, are an independent ranking of the 50 fastest-growing technology companies in the UK, based on percentage growth in revenue over five years. Exco InTouch was placed as the 44th fastest growing company in the country and the 7th fastest growing company in the South East region. Receipt of the Fast 50 award is a significant achievement, recognising growth based on innovation and entrepreneurship. Exco InTouch’s win comes on the back of a recent growth investment from leading growth equity and venture capital group Scottish Equity Partners (SEP).

Mobile patient communication leader to use funds to accelerate growth strategy
Leading growth equity and venture capital group Scottish Equity Partners (SEP) has led an initial £3m pound investment in Exco InTouch, the leading provider of mobile patient communication and management solutions for the pharmaceutical and healthcare sector.

Exco InTouch, has announced that its novel eDiary technologies have been selected by Pfizer, the world’s leading pharmaceutical company, as part of the first ever Participatory Patient-Centered (PPC) clinical trial. The pilot study will utilize Exco InTouch’s leading eDiary technologies to enable patients to participate regardless of location, age or proximity to site.  Focusing on new Research on Electronic Monitoring of OAB Treatment Experience (REMOTE) for the treatment of overactive bladder, the study will mimic a previously completed trial in order to replicate the results and validate this novel approach.

Exco InTouch, is pleased to announce that as part of their Honeymoon Tour, William and Kate will be attending booth #1429 at the 47th Annual Drug Information Association meeting, June 19 – 23, 2011 in Chicago, IL.

On June 7th and 9th 2011, Exco InTouch and Almac Clinical Technologies hosted a Complimentary Web Seminar entitled:

INTEGRATED SOLUTIONS TO INCREASE PATIENT COMPLIANCE AND DELIVER SUCCESS IN YOUR CLINICAL STUDIES

During this webinar, attendees heard from industry experts who discussed how the application of complementary technologies can deliver improved Patient Retention and Compliance.

Data from the latest Experian Simmons National Consumer Study of the US population has led to the identification of five distinct user populations of mobile consumers. This segmentation is based around acceptance and usage of mobile communication technology by the general population. The segments are:

In the US, a study of cell phone users identified that the Hispanic population are 63% more likely than the average cell phone users to be representative of the mobile population. The Hispanic population see their cell phone devices as central part of their everyday lives and as a result they are 33% less likely than average to use their cell phones just for the basics. Also the Hispanic population is more responsive to mobile campaigns, and tailored messaging in the Spanish actively promotes user engagement.

It may not come as a surprise but in the US, the population is more responsive to and reliant on digital communications and technologies in their everyday life. Today’s populace uses a variety of digital channels to do virtually everything, from booking vacations via their mobile phones to researching products on social networking sites. This acceptance of digital media as a communication source has meant that the modern user is becoming less tolerant of any irrelevant messages and more receptive to interconnected and integrated communication.

Exco InTouch, today announced the appointment of Jack Edler as Senior Director of Business Development. This strategic appointment has been timed to coincide with the move of the company’s US operational headquarters to Cary, NC, to enable the continued expansion of the company alongside the improvement of its client hosting facilities. With over 20 years’ extensive experience, Mr. Edler brings with him a unique perspective in helping companies develop, implement and execute global growth strategies to further penetrate healthcare and clinical markets.

The Almac Group and Exco InTouch announced today that Almac’s Clinical Technologies business unit, the leading provider of IXRS® (Interactive Voice and Web Response) services relating to patient and drug supply management, has formed an exclusive integrated patient management alliance with Exco InTouch, an innovative firm specializing in patient recruitment, retention, compliance and ePRO services. The alliance will be focused on the integration of both technology and processes by both firms to deliver patient management, compliance, retention, and ePRO service offerings to sponsors of clinical trials.

Exco InTouch has announced two unique measures which help drive down sponsor costs within clinical trials. The first of these measures is a ’Free SMS’ facility for sponsors who wish to ensure that their text message reminder services for retention and compliance are provided without the patient incurring any costs. The second is the inclusion of a new ’Free Data Download’ feature for Exco InTouch’s mobilePRO (electronic Patient Reported Outcomes using mobile technology) solutions which also removes any direct patient costs.

On the 14th and 15th December 2010, Exco InTouch held a Free Web Seminar entitled: "New Technologies for Retention and Compliance - How enlightened companies are now better able to engage their Patients to ensure successful study conduct."  During the web seminar, participants heard from Richard Mayewski, Patient Recruitment Specialist, Merck & Co Inc and Judith Teall, Director of Patient Recruitment, Exco InTouch who discussed how mobile technology can significantly improve Patient Retention and Compliance in Clinical Trials.

Exco InTouch is pleased to announce that it is sponsoring the ‘2nd Patient Engagement Summit’ taking place at the Crowne Plaza, Downtown Philadelphia on March 1-2, 2011. During this event Judith Teall, Director of Patient Recruitment will be joining Gretchen Goller, Patient Recruitment / Compliance Strategist at Sanofi Aventis and Jeremy Shane President and CEO of HEALTH CENTRAL to host a panel discussion on the use of Mobile Technology as an Engagement Tool to Increase Patient Compliance.

Exco InTouch is pleased to announce that Judith Teall, Director of Patient Recruitment will be presenting at the ‘Patient Recruitment and Retention for Diabetes & Obesity Studies’ conference in Amsterdam on January 28th, 2011.

Exco InTouch, advises that with heightened regulatory standards and the increasing trial complexity and duration of studies, patient non-compliance is a growing issue that requires tailored, cost-effective solutions.  To address these challenges, it is essential to proactively employ strategies that ensure patient compliance in order to avoid compromised data, complete trial failure, or heavy financial losses (through replacement patients and lost revenue days). Successful retention and subject compliance are essential to the completion of a successful trial.